DongTLuMD

Physician

Dr. Lu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Diabetes Recognition Program National Committee for Quality Assurance, 2010-2013
Heart/Stroke Recognition Program National Committee for Quality Assurance, 2010-2013

PubMed

Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.
Rini, B. I., Cohen, D. P., Lu, D. R., Chen, I., Hariharan, S., Gore, M. E., Figlin, R. A., Baum, M. S., Motzer, R. J.> ;J Natl Cancer Inst. 2011 May 4
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.
Raymond, E., Dahan, L., Raoul, J. L., Bang, Y. J., Borbath, I., Lombard-Bohas, C., Valle, J., Metrakos, P., Smith, D., Vinik, A., Chen, J. S., Hörsch, D., Hammel, P., ...> ;N Engl J Med. 2011 Feb 10
Phase II study of sunitinib as second-line treatment for advanced gastric cancer.
Bang, Y. J., Kang, Y. K., Kang, W. K., Boku, N., Chung, H. C., Chen, J. S., Doi, T., Sun, Y., Shen, L., Qin, S., Ng, W. T., Tursi, J. M., Lechuga, M. J., Lu, D. R., Ru...> ;Invest New Drugs. 2011 Dec